Literature DB >> 10583956

Stimulation of bone formation in vitro and in rodents by statins.

G Mundy1, R Garrett, S Harris, J Chan, D Chen, G Rossini, B Boyce, M Zhao, G Gutierrez.   

Abstract

Osteoporosis and other diseases of bone loss are a major public health problem. Here it is shown that the statins, drugs widely used for lowering serum cholesterol, also enhance new bone formation in vitro and in rodents. This effect was associated with increased expression of the bone morphogenetic protein-2 (BMP-2) gene in bone cells. Lovastatin and simvastatin increased bone formation when injected subcutaneously over the calvaria of mice and increased cancellous bone volume when orally administered to rats. Thus, in appropriate doses, statins may have therapeutic applications for the treatment of osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583956     DOI: 10.1126/science.286.5446.1946

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  392 in total

Review 1.  Statins and bones.

Authors:  M H Moghadasian; J J Frohlich
Journal:  CMAJ       Date:  2001-03-20       Impact factor: 8.262

2.  Recombinant human parathyroid hormone.

Authors:  Jonathan Reeve
Journal:  BMJ       Date:  2002-02-23

3.  HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells.

Authors:  J Llevadot; S Murasawa; Y Kureishi; S Uchida; H Masuda; A Kawamoto; K Walsh; J M Isner; T Asahara
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

4.  Effects of randomized rosuvastatin compared with placebo on bone and body composition among HIV-infected adults.

Authors:  Kristine M Erlandson; Ying Jiang; Sara M Debanne; Grace A McComsey
Journal:  AIDS       Date:  2015-01-14       Impact factor: 4.177

5.  The oxysterol, 27-hydroxycholesterol, links cholesterol metabolism to bone homeostasis through its actions on the estrogen and liver X receptors.

Authors:  Erik R Nelson; Carolyn D DuSell; Xiaojuan Wang; Matthew K Howe; Glenda Evans; Ryan D Michalek; Michihisa Umetani; Jeffrey C Rathmell; Sundeep Khosla; Diane Gesty-Palmer; Donald P McDonnell
Journal:  Endocrinology       Date:  2011-09-20       Impact factor: 4.736

6.  Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts.

Authors:  Rongrong Zhang; Babatunde O Oyajobi; Stephen E Harris; Di Chen; Christopher Tsao; Hong-Wen Deng; Ming Zhao
Journal:  Bone       Date:  2012-09-29       Impact factor: 4.398

Review 7.  Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.

Authors:  Christos Hatzigeorgiou; Jeffrey L Jackson
Journal:  Osteoporos Int       Date:  2005-03-03       Impact factor: 4.507

8.  Effects of simvastatin on bone mineral density and remodeling parameters in postmenopausal osteopenic subjects: 1-year follow-up study.

Authors:  Canan Tikiz; Hakan Tikiz; Fatma Taneli; Gül Gümüşer; Ciğdem Tüzün
Journal:  Clin Rheumatol       Date:  2005-03-02       Impact factor: 2.980

Review 9.  Statin therapy in the elderly: does it make good clinical and economic sense?

Authors:  Moira M B Mungall; Allan Gaw; James Shepherd
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 10.  Osteoporosis and diabetes.

Authors:  Diane L Chau; Steven V Edelman; Manju Chandran
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.